Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet — manufactured by Trumac Healthcare

Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Cefpodoxime 200 mg + Clavulanic Acid 125 mg
Form: Tablet
Class: Third-Gen Cephalosporin + Beta-Lactamase Inhibitor (High Strength)
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Ceftru-CV 200 Tablet

Ceftru-CV 200 Tablet

Pack: 10 x 1 x 6 (Alu-Alu)

MRP: ₹2500

View Ceftru-CV 200 Tablet →

Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Cefpodoxime 200 mg + Clavulanic Acid 125 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Complicated community-acquired pneumonia
  • Severe sinusitis with beta-lactamase prevalence
  • Complicated skin and soft-tissue infections
  • Complicated UTI with prior antibiotic exposure
  • Animal/human bite wound infections
Mechanism of Action

Cefpodoxime Proxetil is an oral third-generation cephalosporin prodrug that is hydrolysed in intestinal mucosa to active cefpodoxime. It binds penicillin-binding proteins, inhibiting peptidoglycan cross-linking. Broad spectrum covering gram-negative (H. influenzae, M. catarrhalis, E. coli, Klebsiella) and selected gram-positive (streptococci, MSSA) organisms — including many beta-lactamase-producing strains. Clavulanate inhibits beta-lactamases.

Dosage & Administration
  • Adults: 1 tablet twice daily for 7–14 days.
  • Take with food.
Side Effects
  • Diarrhoea, nausea, vomiting, mild rash, headache.
  • Rare: pseudomembranous colitis, anaphylaxis, severe skin reactions.
  • Cross-reactivity with penicillin allergy (~5–10%).
  • Increased GI upset due to clavulanate.
Contraindications
  • Hypersensitivity to cephalosporins.
  • Severe penicillin allergy.
  • Caution in renal impairment (dose adjustment).
  • Caution in GI disease.
  • History of cholestatic jaundice with clavulanate.
Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise for Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 10 x 1 x 6 (Alu-Alu)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet?

Available pack sizes include: 10 x 1 x 6 (Alu-Alu).

What is the MRP / trade price for Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet?

MRPs range from ₹2500 to ₹2500 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Cefpodoxime 200 mg + Clavulanic Acid 125 mg Tablet?

Get Pricing & Franchise Terms →